PLUS THERAPEUTICS

plus-therapeutics-logo

Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.

#SimilarOrganizations #People #Financial #Website #More

PLUS THERAPEUTICS

Industry:
Biotechnology Medical Therapeutics

Founded:
1996-01-01

Address:
Austin, Texas, United States

Country:
United States

Website Url:
http://www.plustherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
737.255.7194

Email Addresses:
[email protected]

Total Funding:
142.75 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.


Current Advisors List

rick-hawkins_image

Rick Hawkins Director @ Plus Therapeutics
Board_member

not_available_image

Paul W. Hawran Director @ Plus Therapeutics
Board_member

david-m-rickey_image

David M. Rickey Chairman @ Plus Therapeutics
Board_member

Current Employees Featured

marc-hedrick_image

Marc Hedrick
Marc Hedrick President and CEO @ Plus Therapeutics
President and CEO

john-fraser_image

John Fraser
John Fraser Chief Scientist @ Plus Therapeutics
Chief Scientist
2001-01-01

john-ferris_image

John Ferris
John Ferris Senior Director - European Business Development @ Plus Therapeutics
Senior Director - European Business Development
2006-01-01

Founder


christopher-calhoun_image

Christopher Calhoun

ralph-holmes_image

Ralph Holmes

Stock Details


Company's stock symbol is NASDAQ:PSTV

Acquisitions List

Date Company Article Price
2017-02-15 Azaya Therapeutics Azaya Therapeutics acquired by Plus Therapeutics N/A

Investors List

cancer-prevention-and-research-institute-of-texas_image

Cancer Prevention and Research Institute of Texas

Cancer Prevention and Research Institute of Texas investment in Grant - Plus Therapeutics

ge-capital_image

GE Capital

GE Capital investment in Post-IPO Debt - Plus Therapeutics

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Plus Therapeutics

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Plus Therapeutics

Official Site Inspections

http://www.plustherapeutics.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Plus Therapeutics" on Search Engine